StreetAlpha.app
Home › Stocks › NVO

Novo Nordisk a S (NVO)

Healthcare
$40.71
▼ −2.14%
LAST CLOSE · NOV 17

Novo Nordisk makes and sells medicines for obesity, diabetes and rare diseases, and is based in Denmark. It last closed at $40.71 on Nov 17, down 2.14% on the day. NVO reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 2 analysts is $40.00 (-1.7% from the last close), with a high of $40.00 and a low of $40.00. Over the past 90 days StreetAlpha recorded 2 whale options trades in NVO, 100% of them bullish and 0% bearish. In the past 30 days there were 13 dark pool prints totaling $21.6M, the largest $5.7M.

AI Auto Pilots
Is NVO in one of our four AI portfolios? Sign in free to see

Key Stats

Fiscal 2025
Results
Revenue
DKK 309B
+6.4% vs a year ago
Net income
DKK 102B
+1.4% vs a year ago
Free cash flow
DKK 59.0B
19.1% margin
Gross margin
81.0%
DKK 250B gross profit
Balance sheet
Cash & equivalents
DKK 26.5B
At Dec 31
Debt
DKK 131B
At Dec 31
Shareholder equity
DKK 194B
Employees69,505 (Dec 31, 2025)
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: DKK 141BDKK 141BFY2021FY2022: DKK 177BDKK 177BFY2022FY2023: DKK 232BDKK 232BFY2023FY2024: DKK 290BDKK 290BFY2024FY2025: DKK 309BDKK 309BFY2025

From NVO's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 4). Figures are in DKK. Per share figures are left out because the US listing can represent a different number of shares.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$0.68
$11.79B revenue est.
Year-ago EPS
$6.04
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
1 Hold · 1 Sell
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold · 1 Sell
2firms
0 Buy1 Hold1 Sell
Only 2 firms rated NVO in the past 90 days, not enough for a consensus
Average 12-month target
$40.00
▼ 1.7% downside

Based on 2 analysts who set a price target on NVO in the past 90 days. The average target is $40.00, with a high of $40.00 and a low of $40.00, compared with the last close of $40.71.

$36$42$47$53PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $40AVG $40LOW $40May 22LAST CLOSE+12 MO$36$42$47$53PAST 112 DAYSTARGETSHIGH $40AVG $40LOW $40May 22LAST CLOSE+12 MO
Highest target$40.00
Average target$40.00
Lowest target$40.00
Latest rating changes
BMO CapitalMaintained
Oct 12Hold$40
Morgan StanleyDowngrade
Sep 11Sell$40
Goldman SachsDowngrade
Mar 2Hold$41
DateFirmActionRatingPrice target
Oct 12BMO CapitalMaintainedHold$40
Sep 11Morgan StanleyDowngradeSell$40
Mar 2Goldman SachsDowngradeHold$41
Loading…

Technical Analysis

NVO · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend

The stock is 1% above its 20 day and 2% above its 50 day average. It is 6% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 52). The nearest support is the Pivot at $40.63, and the nearest resistance the Pivot R1 at $41.04.

Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 2.7%/day
Key levels
$64.1652 week high+57.6%
$43.86100 day average+7.7%
$43.24Swing high (Nov 4)+6.2%
$43.00200 day average+5.6%
$41.04Pivot R1+0.8%
$40.71Last close
$40.63Pivot−0.2%
$40.31Pivot S1−1.0%
$40.2020 day average−1.3%
$40.08Swing low (Nov 12)−1.5%
$39.9050 day average−2.0%
$35.1252 week low−13.7%
Indicators
RSI (14)52.13Middle of its rangeNeutral
MACD0.40Above its signal lineBullish
Stochastic61.5Middle of its rangeNeutral
ADX (14)18.8No clear trend
Williams %R-54.1Oversold below −80, overbought above −20Neutral
CCI (20)35.1Oversold below −100, overbought above 100Neutral
Rate of change+1.3%Change over 10 sessionsBullish
ATR (14)$1.08Typical daily range, 2.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Below
What happened before, for NVO

What happened before

See how NVO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow NVO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How NVO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
2
100%
Bearish
0
0%
Date span
Aug 20 – Sep 23
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
13
Notional
$21.6M
Largest print
$5.7M
Loading…

NVO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼478 buying vs 712 selling
  • ▲Shares held by funds +1.2%
  • ▼Funds holding -129
  • ▲Superinvestors: 5 added, 0 cut
  • ▲Put/call 1.50 to 1.37
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding1,2301,359−9.5%
In funds' top 10814−42.9%
Held by funds–––
New / increased92 / 386199 / 462−27.7%
Reduced / sold out504 / 208458 / 122+22.8%
Put/call ratio1.371.50−9.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NVO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NVO is in one of them and how their past NVO trades turned out.

NVO in the AI portfolios
Loading…

NVO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NVO in an article yet. Here's the latest on the wider market.

NVO Congress Trades

All congress trades →
Trades, 12 months
8
Buys
4
50%
Sells
4
50%
People
4
Last filed Sep 28
Who traded NVO · since 2017
Latest 5 filings of 72
$1K – $15KTraded Sep 10, 2026Filed Sep 28, 2026
$1K – $15KTraded Aug 31, 2026Filed Sep 28, 2026
$1K – $15KTraded Aug 26, 2026Filed Sep 18, 2026
$1K – $15KTraded Aug 26, 2026Filed Sep 18, 2026
$15K – $50KTraded Mar 30, 2026Filed Jul 21, 2026
PersonTypeAmountTradedFiledDelay
Kevin HernR · OKSell$1K – $15KSep 10, 2026Sep 28, 202618 d
Kevin HernR · OKSell$1K – $15KAug 31, 2026Sep 28, 202628 d
Clifford FranklinR · FLBuy$1K – $15KAug 26, 2026Sep 18, 202623 d
Clifford FranklinR · FLBuy$1K – $15KAug 26, 2026Sep 18, 202623 d
Alan ArmstrongHouseBuy$15K – $50KMar 30, 2026Jul 21, 2026113 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Novo Nordisk a S

Novo Nordisk is a healthcare company based in Bagsvaerd, Denmark, that discovers, develops, makes and sells pharmaceutical products. Its main focus is obesity and diabetes care, with products including insulin and medicines for weight management and type 2 diabetes. It also sells treatments for rare diseases, mainly growth hormone and haemophilia products. Its customers include patients, doctors and healthcare systems worldwide.

Headquarters
Bagsvaerd Denmark, Denmark